Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)
Futa Koga, Yasunori Kawaguchi, Mototsugu Shimokawa, Kenichiro Murayama, Shunya Nakashita, Noriko Oza, Norio Ureshino, Hirokazu Takahashi, Yujiro Ueda, Junichi Nakazawa, Azusa Komori, Satoshi Otsu, Shiho Arima, Masaru Fukahori, Akitaka Makiyama, Hiroki Taguchi, Takuya Honda, Taro Shibuki, Kenta Nio, Yasushi Ide, Toshihiko Mizuta, Tsuyoshi Shirakawa, Taiga Otsuka, Kenji Mitsugi
Topics & Concepts
MedicineGemcitabineInternal medicinePancreatic cancerPost-hoc analysisAdverse effectPaclitaxelChemotherapyPerformance statusMalignancyCancerOncologyPancreatic and Hepatic Oncology ResearchNutrition and Health in AgingRenal cell carcinoma treatment